Literature DB >> 26503927

Decade in review-migraine: incredible progress for an era of better migraine care.

Peter J Goadsby1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26503927     DOI: 10.1038/nrneurol.2015.203

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

Review 1.  Diencephalic and brainstem mechanisms in migraine.

Authors:  Simon Akerman; Philip R Holland; Peter J Goadsby
Journal:  Nat Rev Neurosci       Date:  2011-09-20       Impact factor: 34.870

2.  Provocation of migraine with aura using natural trigger factors.

Authors:  Anders Hougaard; Faisal Mohammad Amin; Faisal Amin; Anne Werner Hauge; Messoud Ashina; Jes Olesen
Journal:  Neurology       Date:  2013-01-23       Impact factor: 9.910

3.  From migraine genes to mechanisms.

Authors:  Else A Tolner; Thijs Houben; Gisela M Terwindt; Boukje de Vries; Michel D Ferrari; Arn M J M van den Maagdenberg
Journal:  Pain       Date:  2015-04       Impact factor: 6.961

4.  Vasoactive peptide release in the extracerebral circulation of humans during migraine headache.

Authors:  P J Goadsby; L Edvinsson; R Ekman
Journal:  Ann Neurol       Date:  1990-08       Impact factor: 10.422

5.  Suppression of cortical spreading depression in migraine prophylaxis.

Authors:  Cenk Ayata; Hongwei Jin; Chiho Kudo; Turgay Dalkara; Michael A Moskowitz
Journal:  Ann Neurol       Date:  2006-04       Impact factor: 10.422

Review 6.  CGRP and its receptors provide new insights into migraine pathophysiology.

Authors:  Tony W Ho; Lars Edvinsson; Peter J Goadsby
Journal:  Nat Rev Neurol       Date:  2010-09-07       Impact factor: 42.937

7.  Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system.

Authors:  P J Goadsby; L Edvinsson; R Ekman
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

8.  Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study.

Authors:  Faisal Mohammad Amin; Mohammad Sohail Asghar; Anders Hougaard; Adam Espe Hansen; Vibeke Andrée Larsen; Patrick J H de Koning; Henrik B W Larsson; Jes Olesen; Messoud Ashina
Journal:  Lancet Neurol       Date:  2013-04-09       Impact factor: 44.182

9.  Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks.

Authors:  Farooq Husain Maniyar; Till Sprenger; Teshamae Monteith; Christoph Schankin; Peter James Goadsby
Journal:  Brain       Date:  2013-11-25       Impact factor: 13.501

Review 10.  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2015-06-07       Impact factor: 202.731

  10 in total
  6 in total

Review 1.  Pathophysiology of Migraine: A Disorder of Sensory Processing.

Authors:  Peter J Goadsby; Philip R Holland; Margarida Martins-Oliveira; Jan Hoffmann; Christoph Schankin; Simon Akerman
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

2.  Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine.

Authors:  Anna P Andreou; Philip R Holland; Simon Akerman; Oliver Summ; Joe Fredrick; Peter J Goadsby
Journal:  Brain       Date:  2016-05-30       Impact factor: 13.501

3.  Anxiety and depression symptoms and migraine: a symptom-based approach research.

Authors:  Mario Fernando Prieto Peres; Juliane P P Mercante; Patricia R Tobo; Helder Kamei; Marcelo Eduardo Bigal
Journal:  J Headache Pain       Date:  2017-03-21       Impact factor: 7.277

4.  Acupuncture for emotional disorders in patients with migraine: a systematic review protocol.

Authors:  Ning Sun; Mingsheng Sun; Zhengjie Li; Rui-Rui Sun; Ling Zhao; Jiao Chen; Fan-Rong Liang
Journal:  BMJ Open       Date:  2020-01-06       Impact factor: 2.692

5.  Metabotropic glutamate receptor 5: a target for migraine therapy.

Authors:  Maggie W Waung; Simon Akerman; Mark Wakefield; Charlotte Keywood; Peter J Goadsby
Journal:  Ann Clin Transl Neurol       Date:  2016-07-01       Impact factor: 4.511

6.  Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1 receptor: implications for migraine.

Authors:  Margarida-Martins Oliveira; Simon Akerman; Isaura Tavares; Peter J Goadsby
Journal:  Pain       Date:  2016-08       Impact factor: 7.926

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.